In short: Online weight-management and hormone-care services can offer genuine clinical oversight, but they are not interchangeable, and neither is right for everyone. Before booking an assessment, confirm who is actually prescribing, whether your medication is FDA-approved or compounded, what monitoring is included, and — critically for UK readers — whether the service can legally treat you at all. Most reputable telehealth platforms of this kind are US-based and restricted to patients physically located in specific US states, so a service that looks appealing online may not be able to treat someone in the UK, regardless of how the marketing reads.
Key Takeaways
- Weight management and hormone care are distinct clinical decisions with different tests, medications, and monitoring — don’t let one “assessment” blur the two.
- Ask whether a prescription would be an FDA-approved branded product or a compounded preparation; the two are not legally equivalent, and compounded drugs are not FDA-reviewed for safety or effectiveness.
- Confirm the prescriber’s name, licence, and specialty before paying anything.
- US telehealth is bound by state licensure. A provider serving “all 50 states” still cannot treat patients outside the US — worth checking before you sign up.
- Ongoing labs, dose adjustments, and a plan for stopping treatment separate managed care from a one-off prescription.
- Severe abdominal pain, allergic reaction, or chest pain after starting a medication is an emergency-department matter, not a message to a telehealth portal.
Two different questions, not one
“Should I lose weight?” and “should I address a hormone imbalance?” sound similar, and many online clinics now offer both under one roof. But they are distinct clinical questions with different biology, contraindications, and follow-up. A GLP-1 medication prescribed for appetite regulation and a hormone therapy prescribed for menopausal or low-testosterone symptoms are not treated with the same rigour by default just because one company offers both — ask about each separately.
Who is actually treating you
A legitimate telehealth service should tell you, before payment, which licensed clinicians review cases and what their credentials are — medical licence, board certification, specialty. Some platforms are built by non-clinical founders with prescribing handled by a separate roster of physicians. That can be appropriate, but understand who is legally responsible for your care versus who runs the business.
Ask: What is the prescriber’s name, licence type, and board certification? Does the same clinician review my labs and my history?
Diagnosis and eligibility before treatment
A credible provider requires real clinical assessment — a live video or phone visit plus bloodwork — not just a symptom questionnaire. For weight management, expect metabolic and hormonal labs rather than a single BMI cut-off. For hormone therapy, expect confirmation on more than one blood draw (testosterone is usually confirmed low on repeat morning testing) and a check of thyroid function, since thyroid problems, iron deficiency, sleep apnoea, and depression can mimic a hormone problem.
Ask: What tests are required before anything is prescribed? Is there a live consultation, or only a form? What would disqualify me?
Medication sourcing: branded versus compounded
This is one of the most consequential and least understood questions. Many online weight-management and hormone programmes prescribe compounded versions of drugs such as semaglutide or tirzepatide, made by a compounding pharmacy rather than the original drugmaker. The US Food and Drug Administration is explicit that compounded medications are not FDA-approved, are not evaluated by the agency for safety or effectiveness, and are not interchangeable with the approved branded product (FDA guidance on compounding). That doesn’t make a compounded drug automatically unsafe, but the clinical trial results reported for a branded product don’t transfer to a compounded version — know which one you’re being offered.
Ask: Is this FDA-approved or compounded? If compounded, which pharmacy prepares it, and why this instead of the branded product?
Contraindications and side effects
Every category here has real exclusions. GLP-1 medications are generally avoided in pregnancy or while trying to conceive, and in people with a personal or family history of certain thyroid cancers or Multiple Endocrine Neoplasia type 2. Menopausal hormone therapy is generally not appropriate with undiagnosed vaginal bleeding, active breast or endometrial cancer, or a history of certain blood clots. Testosterone therapy is not appropriate with active prostate cancer, untreated severe sleep apnoea, or for men trying to conceive soon, since it can suppress fertility. Side effects differ too: GLP-1s are typically gastrointestinal (nausea most common); hormone therapy effects vary by route and formulation. A responsible provider walks through these before you start.
Ask: What are the specific exclusions for this medication? What side effects are common, and what should prompt urgent contact?
Monitoring, labs, and ongoing care
A one-time prescription is not the same as managed care. Reputable programmes recheck relevant bloodwork on a defined schedule — testosterone therapy typically includes haematocrit and PSA, since testosterone can affect blood thickness and prostate markers; hormone therapy follow-up is often based on symptom response as much as a single lab value. Ask what happens if a marker moves out of range, and whether dose changes are based on symptoms, labs, or both.
Ask: How often are labs repeated? Who reviews results and adjusts dose? What happens if something moves out of range?
Privacy, cost, and cancellation
Telehealth intake forms collect sensitive medical history — ask how it’s stored, whether it’s shared with third parties (including pharmacies or marketing partners), and how to request deletion. Read the privacy policy before filling out a health questionnaire, not after.
On cost, the US Federal Trade Commission has taken enforcement action against telehealth weight-loss marketers over undisclosed fees and vague membership commitments (FTC press release, December 2025). Before paying, get the full picture: Is there a membership fee separate from medication cost? Is pricing the same regardless of who’s asking? Are labs included or billed separately? Is cancellation straightforward? Providers publishing full pricing with no hidden minimum commitment are easier to trust and compare.
Realistic expectations and stopping treatment
No credible clinician promises a specific outcome. Weight regulation and hormone levels both involve individual variation, and effects such as appetite suppression from a GLP-1 generally recede after stopping — sustainable results depend on habits built alongside medication, not the drug alone. Ask what a realistic timeline looks like and whether there’s a plan for tapering or reassessing continued use; sound hormone-therapy guidance supports periodic reassessment rather than indefinite renewal by default.
Service boundaries: a question UK readers must not skip
Because providers like ACT 2 Health are US telehealth operations, licensure is granted state by state, and clinicians can only treat patients physically located in a state where they hold a licence at the time of consultation. Care is therefore restricted to US-based patients — worth checking explicitly rather than assumed. Some providers publish exactly which jurisdictions and services are covered, including carve-outs (some US states restrict direct-to-consumer lab ordering even where clinical care is otherwise available); ACT 2 Health’s state-by-state breakdown is a useful example of that kind of transparency. For UK readers, this isn’t a formality — it determines whether a given US provider can treat you at all, and most cannot.
When to seek urgent care instead of messaging a provider
Telehealth is not built for emergencies. Seek immediate in-person care (in the UK, call 999 or go to A&E; in the US, call 911) for: severe or persistent abdominal pain, signs of an allergic reaction (facial or throat swelling, breathing difficulty), chest pain, fainting, or sudden painful leg swelling suggesting a blood clot. Don’t wait for a message reply from any online provider for these symptoms.
Quick checklist before you book
- ☐ Prescriber’s name, licence, and board certification confirmed
- ☐ Live clinical assessment required before prescribing, not just a form
- ☐ Clear statement: FDA-approved or compounded medication
- ☐ Contraindications and side effects explained specifically
- ☐ Monitoring schedule and lab plan set out in writing
- ☐ Privacy policy read and understood
- ☐ Full pricing, including recurring fees, provided upfront
- ☐ Cancellation and tapering process explained
- ☐ Jurisdiction and eligibility confirmed for your actual location
FAQs
Are online weight-management and hormone services legitimate? Many are, provided they involve licensed clinicians, real diagnostic assessment, and ongoing monitoring. Legitimacy depends on the specific provider’s practices, not the delivery model itself.
Can a US telehealth provider treat me if I live in the UK? Generally no. US clinicians are licensed state by state and typically can only treat patients physically located in the US at the time of consultation. Check this explicitly before assuming coverage.
Is a compounded medication less safe than a branded one? Not necessarily unsafe, but legally different: compounded drugs are not FDA-approved and are not reviewed by the FDA for safety or effectiveness the way the branded product is. Ask which you’re being prescribed, and why.
Do I need bloodwork before starting hormone therapy or a GLP-1 medication? Reputable providers require it, to confirm eligibility, rule out other causes of symptoms, and provide a baseline for future monitoring.
What if I have side effects after starting? Report them to your prescriber promptly — many can be managed with dose adjustments. Severe symptoms (see the urgent-care section above) need immediate in-person care, not a telehealth message.
This article is general information for a UK wellbeing audience and is not medical advice. It does not recommend any specific treatment. Speak with a qualified, appropriately licensed clinician about your own circumstances before starting or stopping any medication.
Sources consulted: U.S. Food and Drug Administration (compounding guidance and GLP-1 safety communications); U.S. Federal Trade Commission (consumer alerts on weight-loss marketing and telehealth enforcement); MedlinePlus (U.S. National Library of Medicine) drug information; American College of Obstetricians and Gynecologists guidance on menopause hormone therapy; act2health.com service, pricing, physician, and state-availability pages (reviewed September 2026).
- About the Author
- Latest Posts
Our Editorial Team are writers and experts in their field. Their views and opinions may not always be the views of Wellbeing Magazine. If you are under the direction of medical supervision please speak to your doctor or therapist before following the advice and recommendations in these articles.
